$ USD
¥ 人民币
$ USD
€ 欧元
English
简体中文
English
繁体中文
Sign In / Sign up
Home page
News
Tumor Information
Tumor Information
Tumor medication
Tumor medication
Drug data
Drug data
Tumor medication
Oncology
renal cell carcinoma
cell tumor
solid tumors
IDH1 mutation
non-small cell lung cancer
neurofibromatosis
liposarcoma
neurofibromatosis
Cachexia
bladder cancer
Common Medications
Common medications
Hematology
Hepatobiliary
chronic disease
Endocrinology
Rare disease drugs
Other medications
insomnia
depression
chronic cough
kidney transplant
Drug Classification
Brand Medicine Search
Brand Medicine Search
日本日医工株式会社
日本盐野义制药
日本杏林制药株式会社
日本株式会社
老挝卢修斯
hormone receptor positive
constipate
heart disease
constipate
depression
日本株式会社
日本田边三菱
英国FuturaMedical制药
日本盐野义制药
日本杏林制药株式会社
Medical Q&A
Medical Q&A
About Us
About Us
Menu
Home page
News
Tumor Information
Tumor Information
Tumor medication
Tumor medication
Drug data
Drug data
Tumor medication
Oncology
renal cell carcinoma
cell tumor
solid tumors
IDH1 mutation
non-small cell lung cancer
neurofibromatosis
liposarcoma
neurofibromatosis
Cachexia
bladder cancer
Common Medications
Common medications
Hematology
Hepatobiliary
chronic disease
Endocrinology
Rare disease drugs
Other medications
insomnia
depression
chronic cough
kidney transplant
Drug Classification
Brand Medicine Search
Brand Medicine Search
日本日医工株式会社
日本盐野义制药
日本杏林制药株式会社
日本株式会社
老挝卢修斯
hormone receptor positive
constipate
heart disease
constipate
depression
日本株式会社
日本田边三菱
英国FuturaMedical制药
日本盐野义制药
日本杏林制药株式会社
Medical Q&A
Medical Q&A
About Us
About Us
Home
News
News
Medical Halo Global Pharmaceutical News_Targeted Drugs_New Anti-Cancer Drugs_Overseas Medical Information_【Medical Halo Global Pharmaceutical】
抗癌靶向药物雷莫芦单抗的治疗效果
2025-10-19 11:44:20
Check Details
非小细胞肺癌第三代靶向药物-劳拉替尼
2025-10-19 11:44:20
Check Details
抗肺癌药物劳拉替尼去哪可以买到?
2025-10-19 11:44:20
Check Details
肺癌治疗用药劳拉替尼效果好吗?
2025-10-19 11:44:20
Check Details
肺癌第三代靶向药劳拉替尼进入医保了吗?
2025-10-19 11:44:20
Check Details
雷莫芦单抗(Ramucirumab)治疗转移性肺癌效果
2025-10-19 11:44:20
Check Details
肺癌靶向药劳拉替尼(Lorlatinib)多少钱一盒?
2025-10-19 11:44:20
Check Details
劳拉替尼(Lorlatinib)治疗肺癌效果
2025-10-19 11:44:20
Check Details
雷莫芦单抗(Ramucirumab)治疗转移性肺癌的效果
2025-10-19 11:44:20
Check Details
雷莫芦单抗(Ramucirumab)治疗转移性肺癌怎么样
2025-10-19 11:44:20
Check Details
雷莫芦单抗对EGFR阳性肺癌的治疗新挑战
2025-10-19 11:44:20
Check Details
肺癌服用劳拉替尼治疗的效果
2025-10-19 11:44:20
Check Details
1
2
...
9723
9724
9725
9726
9727
9728
9729
...
10205
10206
Category
Oncology
Hepatobiliary
dermatology
Endocrinology
Hematology
Andrology
Gynecology
Nephrology
Urology
Department of Infectious Diseases
Gastroenterology
Respiratory department
Neurology
Cardiology and Brain Department
ophthalmology
Psychiatry
Immunology Department
orthopedics
Burn Department
相关知识
1
RAS Targeted Therapy Resistance Breakthrough: mTORC1 is Key, Dalifarnib Combination Therapy Brings Hope
2
ARID1A Gene: A New Breakthrough in Tumor Immunotherapy, Turning "Cold Tumors" Hot
3
Alectinib for ALK-Positive Lung Cancer: Efficacy, Side Effects & Clinical Outlook
4
Mavacamten (Maifantuo): A Targeted Therapy for Obstructive Hypertrophic Cardiomyopathy
5
Remibrutinib (Ruipoduo): Safety, Side Effects, and Usage Guidelines
6
Which Generation TKI Is Repotrectinib? Professional Analysis of Next-Gen ROS1 Inhibitor Classification and Clinical Features
7
Brigatinib for NF2 Neurofibromatosis: Mechanism, Efficacy and Prospects
8
Dietary Guide During Goserelin Treatment: Scientific Nutrition Management to Alleviate Side Effects and Improve Quality of Life.
9
CYP26A1 Gene Emerges as New Target for Colorectal Cancer Treatment! Folate Metabolism Research Brings Hope for Immunotherapy.
10
Precision Breakthrough: Inavolisib Redefines Survival in PIK3CA-Mutant Breast Cancer
11
Romiplostim vs. Eltrombopag: ITP Treatment Dosing Differences and Precision Selection
12
Asciminib: Mechanism and Clinical Value of the First ABL Allosteric Inhibitor